Search
CELL BANK Website

Back Back
RCB0469 : Lu-139  update : 2018/07/31
CommentSmall cell carcinoma, classic type. Application consideration
Comment from the depositor
Terms and conditionsBasically, there is no restriction regarding academic use.
Remarks
Order Form Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, Category I and II, depending on the sort of user institutions and the purposes of use.Please use an appropriate MTA(to see).In case of Restriction "a" or "f", please contact RIKEN BRC(cellbank.brc@riken.jp) regarding any kind of for-profit use.
Basic information Depositor Terasaki, Takeo
Originator Tsumuraya, M. & Nakajima, T.
Year of deposit 1990
Animal human < Mammals
Genus Homo
Species sapiens
Race Japanese
Gender Male
Age at sampling 63 years
Tissue lung
Case history small cell carcinoma
Classification cancer
Year of origin 1986
History M. Tsunuraya
Lifespan infinite
Morphology other
deposit info
lot info
Medium Medium List
Culture type Suspension cells
Medium and additives RPMI1640 + 10% FBS
Antibiotics Free
Passage method dilution
Culture information Passage ratio 1 : 10 split
SC frequency Subculture : once/week, Medium Renewal : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
STR (human) OK
Virus (HIV) (-)
Isozyme LD, NP
Chromosome mode 54-138(50) : /65(2),66(44),67(13),68(22),69(1)/
Images
deposit info
lot info
Reference information Reference 10
User's Publication 12


To topTop
Reference
1368  Relation between nucleolar size and growth characteristics in small cell lung cancer cell lines.  Matsumoto T, Terasaki T, Mukai K, Wada M, Okamoto A, Yokota J, Yamaguchi K, Kato K, Nagatsu T, Shimosato Y  Jpn J Cancer Res   1991  82:820-8  PubMed ID: 1715338
3142  Levels of glutathione S transferase pi mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin.  Nakagawa K, Yokota J, Wada M, Sasaki Y, Fujiwara Y, Sakai M, Muramatsu M, Terasaki T, Tsunokawa Y, Terada M, et al.  Jpn J Cancer Res  1988  79:301-4  PubMed ID: 2836347
1112  Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes.  Yokota J, Wada M, Yoshida T, Noguchi M, Terasaki T, Shimosato Y, Sugimura T, Terada M  Oncogene  1988  2:607-11  PubMed ID: 2838790
1111  Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung.  Yokota J, Akiyama T, Fung, Y K, Benedict, W F, Namba Y, Hanaoka M, Wada M, Terasaki T, Shimosato Y, Sugimura T, et al.  Oncogene  1988  3:471-5  PubMed ID: 2856251
1118  Changes in cell characteristics due to culture conditions in cell lines from human small cell lung cancer.  Terasaki T, Shimosato Y, Nakajima T, Tsumuraya M, Morinaga S, Hirohashi S, Yamaguchi K, Kato K, Ichinose H, Nagatsu T  Jpn J Clin Oncol  1986  16:203-12  PubMed ID: 3022030
3144  Isolation and sequence analysis of human cadherin-6 complementary DNA for the full coding sequence and its expression in human carcinoma cells.  Shimoyama Y, Gotoh M, Terasaki T, Kitajima M, Hirohashi S  Cancer Res  1995  55:2206-11  PubMed ID: 7743525
3140  Alternative splicing of the neurofibromatosis 1 gene correlates with growth patterns and neuroendocrine properties of human small-cell lung-carcinoma cells.  Koh T, Yokota J, Ookawa K, Kina T, Koshimura K, Miwa S, Ariyasu T, Yamada H, Osaka M, Haga H, et al.  Int J Cancer  1995  60:843-7  PubMed ID: 7896456
3148  Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines.  Gemma A, Takenoshita S, Hagiwara K, Okamoto A, Spillare, E A, McMemamin, M G, Hussain, S P, Forrester K, Zariwala M, Xiong Y, Harris, C C  Int J Cancer  1996  68:605-11  PubMed ID: 8938142
3150  Development and elongation of neurite-like outgrowth on small cell lung cancer cell lines  Tanaka K, Terasaki T  Oncogene  1997  88:176-183  PubMed ID: 9119746
3149  Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers.  Gemma A, Hosoya Y, Seike M, Uematsu K, Kurimoto F, Hibino S, Yoshimura A, Shibuya M, Kudoh S, Emi M  Lung Cancer  2001  32:289-95  PubMed ID: 11390010

To topTop
User's Publication
2929  Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles  Jones MH, Virtanen C, Honjoh D, Miyoshi T, Satoh Y, Okumura S, Nakagawa K, Nomura H, Ishikawa Y  Lancet  2004  63:775-781  PubMed ID: 15016488
1783  Characterization of four new cell lines derived from small-cell gastrointestinal carcinoma.  Fujiwara T, Motoyama T, Ishihara N, Watanabe H, Kumanishi T, Kato K, Ichinose H, Nagatsu T  Int J Cancer  1993  54:965-71  PubMed ID: 8392984
2214  Expression of neural cell adhesion molecule L1 in human lung cancer cell lines.  Katayama M, Iwamatsu A, Masutani H, Furuke K, Takeda K, Wada H, Masuda T, Ishii K  Cell Struct Funct  1997  22:511-6  PubMed ID: 9431455
3338  Proteomic signature of human cancer cells.  Seike, Masahiro, Kondo, Tadashi, Fujii, Kazuyasu, Yamada, Tesshi, Gemma, Akihiko, Kudoh, Shoji, Hirohashi, Setsuo  Proteomics  2004  4:2776-88  PubMed ID: 15352251
7379  Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.  Matsumoto M, Seike M, Noro R, Soeno C, Sugano T, Takeuchi S, Miyanaga A, Kitamura K, Kubota K, Gemma A.  BMC Cancer  2015  15:241  PubMed ID: 25884680
9502  PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth.  Morita M, Sato T, Nomura M, Sakamoto Y, Inoue Y, Tanaka R, Ito S, Kurosawa K, Yamaguchi K, Sugiura Y, Takizaki H, Yamashita Y, Katakura R, Sato I, Kawai M, Okada Y, Watanabe H, Kondoh G, Matsumoto S, Kishimoto A, Obata M, Matsumoto M, Fukuhara T, Motohashi H, Suematsu M, Komatsu M, Nakayama KI, Watanabe T, Soga T, Shima H, Maemondo M, Tanuma N.  Cancer Cell  2018  33:355-367.e7  PubMed ID: 29533781
10922  Loss of IL-24 expression facilitates invasion in lung adenocarcinoma     Int J Clin Exp Pathol  2017  10:173-185 
11097  An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.  Horie M, Miyashita N, Mattsson JSM, Mikami Y, Sandelin M, Brunnstrom H, Micke P, Nagase T, Saito A.  J. Pathol.  2018  246(2):154-165  PubMed ID: 29876935
11373  A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition.  Mahoney CE, Pirman D, Chubukov V, Sleger T, Hayes S, Fan ZP, Allen EL, Chen Y, Huang L, Liu M, Zhang Y, McDonald G, Narayanaswamy R, Choe S, Chen Y, Gross S, Cianchetta G, Padyana AK, Murray S, Liu W, Marks KM, Murtie J, Dorsch M, Jin S, Nagaraja N, Biller SA, Roddy T, Popovici-Muller J, Smolen GA.  Nat Commun  2019    PubMed ID: 30626880
6407  Gastrin receptor gene expression in several human carcinomas.  Matsushima Y, Kinoshita Y, Nakata H, Inomoto-Naribayashi Y, Asahara M, Kawanami C, Nakamura A, Ito M, Matsui T, Fujiwara T, et al.  Jpn J Cancer Res  1994  85(8):819-24  PubMed ID: 7928627
4390  POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.  Ishii J, Sato H, Sakaeda M, Shishido-Hara Y, Hiramatsu C, Kamma H, Shimoyamada H, Fujiwara M, Endo T, Aoki I, Yazawa T.  Pathol Int  2013  63(3):158-68  PubMed ID: 23530560
6410  Is parainfluenza virus a threatening virus for human cancer cell lines?  Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.  Hum Cell  2009  22(3):81-4  PubMed ID: 19624309



Back Back Return Top Page